Apixaban Cuts Stroke But Ups Bleeding in Subclinical AF Apixaban Cuts Stroke But Ups Bleeding in Subclinical AF

Further analyses from the ARTESIA study and the previous NOAH-AFNET 6 trial are needed to try to identify groups where the benefit may outweigh the risk, researchers say.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
More News: Bleeding | Cardiology | Heart | Stroke | Study